Brigitte

Brigitte Angres, Pfullingen DE

Patent application number	Description	Published
20110079513	MICROFLUIDIC SYSTEM AND METHOD FOR ASSEMBLING AND FOR SUBSEQUENTLY CULTIVATING, AND SUBSEQUENT ANALYSIS OF COMPLEX CELL ARRANGEMENTS - A microfluidic system (	04-07-2011
20120199487	MICROFLUIDIC SYSTEM AND METHOD FOR ASSEMBLING AND FOR SUBSEQUENTLY CULTIVATING, AND SUBSEQUENT ANALYSIS OF COMPLEX CELL ARRANGEMENTS - The present invention provides an apparatus and a method to assemble organotypical tissues which can then be perfused and investigated under preferably physiological conditions. This is achieved by a microfluidic system for assembling and subsequently cultivating complex cell arrangements, comprising: a three-dimensional microstructure in which the cell arrangement is assembled and cultivated, at least two microchannel segments running in the microstructure and defining a flow direction, through which microchannel segments the microstructure can be perfused from outside with a medium, whereby the microchannel segments run approximately parallel or equidistant to one another at least in sections, a wall structure which separates the at least two microchannel segments and in which at least one aperture connecting the at least two microchannel segments is provided, and an electrode arrangement provided in or on the microstructure in order to generate an inhomogeneous electric field in the region of the at least one aperture.	08-09-2012
20130156819	ISOLATION OF MESENCHYMAL STEM CELLS - The present invention relates to peptides or fragments thereof, which peptides bind to mesenchymal stem cells. The present invention also relates to a method for identifying, isolating, specifically selecting and/or enriching mesenchymal stem cells, wherein the peptides, or fragments thereof, are employed for specifically binding to the mesenchymal stem cells. Also, the present invention relates to the use of the peptides of the invention, or fragments thereof, and of the mesenchymal stem cells isolated with the peptides of the invention, or fragments thereof, for treating, injuries and/or degenerated bone, cartilage or tissues.	06-20-2013

Brigitte Annerl, Wien AT

Brigitte Assouline, Courbevoie FR

Patent application number	Description	Published
20080206190	Glycosylated IL-7, Preparation And Uses - The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.	08-28-2008
20100196312	GLYCOSYLATED IL-7, PREPARATION AND USES - The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.	08-05-2010
20120016104	GLYCOSYLATED IL-7, PREPARATION AND USES - The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.	01-19-2012
20140377218	HCV IMMUNOTHERAPY - The invention relates to the use of Interleukin-7 (IL-7), for treating hepatitis C in a patient infected with hepatitis C virus, wherein said patient has been treated or is being treated with an antiviral agent or a combination of antiviral agents that reduces viral load.	12-25-2014

Brigitte Autran, Paris FR

Patent application number	Description	Published
20100093007	Method of Diagnosis of Tuberculosis Related Immune Restoration Syndrome (IRS) - The present invention relates to a method and kit of diagnosis of Immune Restoration Syndrome associated with tuberculosis (TB-IRS) in patients infected with tuberculosis (TB) as well as in HIV co-infected patients comprising detecting an acute increase in Th1 response following exposure to mycobacterial extract, referred as tuberculin or PPD (Purified Protein Derivative) as well as to the 16 kDa protein, but not to ESAT-6 or CFP-10, two antigens from	04-15-2010
20100285099	VACCINATION BY TRANSCUTANEOUS TARGETING - The present invention relates to a method of vaccination via hair follicles that makes it possible to target vaccine components to the antigen-presenting cells in order to induce a protective and effective immune response against pathogens.	11-11-2010
20110311992	Method of Prognosis and/or Diagnosing an IRS in a Patient Infected with M. Tuberculosis and Optionally HIV - The invention relates to a method of prognosing and/or diagnosing a	12-22-2011

Brigitte Bandl-Konrad, Goeppingen DE

Patent application number	Description	Published
20110005204	Exhaust Gas Aftertreatment Installation and Method - An exhaust gas aftertreatment installment and associated exhaust gas aftertreatment method utilizes a nitrogen oxide storage catalytic converter and an SCR catalytic converter. A particulate filter is provided upstream of the nitrogen oxide storage catalytic converter or between the latter and the SCR catalytic converter or downstream of the SCR catalytic converter. The time of regeneration operating phases of the nitrogen oxide storage catalytic converter can be determined as a function of the nitrogen oxide content of the exhaust gas downstream of the nitrogen oxide storage catalytic converter or of the SCR catalytic converter and/or as a function of the ammonia loading of the latter. Moreover, a desired ammonia generation quantity can be determined for a respective regeneration operating phase. The installation and method are adopted for use for motor vehicle internal combustion engines and other engines which are operated predominantly in lean-burn mode.	01-13-2011
20130011313	Exhaust Gas Aftertreatment Installation and Method - An exhaust gas aftertreatment installment and associated exhaust gas aftertreatment method utilizes a nitrogen oxide storage catalytic converter and an SCR catalytic converter. A particulate filter is provided upstream of the nitrogen oxide storage catalytic converter or between the latter and the SCR catalytic converter or downstream of the SCR catalytic converter. The time of regeneration operating phases of the nitrogen oxide storage catalytic converter can be determined as a function of the nitrogen oxide content of the exhaust gas downstream of the nitrogen oxide storage catalytic converter or of the SCR catalytic converter and/or as a function of the ammonia loading of the latter. Moreover, a desired ammonia generation quantity can be determined for a respective regeneration operating phase. The installation and method are adopted for use for motor vehicle internal combustion engines and other engines which are operated predominantly in lean-burn mode.	01-10-2013

Brigitte Baretzky, Heilbronn DE

Patent application number	Description	Published
20120258243	METHOD AND APPARATUS FOR PRODUCING A FRESNEL ZONE PLATE - A method of producing a Fresnel zone plate (	10-11-2012

Brigitte Bauer, Goteborg SE

Patent application number	Description	Published
20110143385	PLASMA MEMBRANE VESICLES AND METHODS OF MAKING AND USING SAME - The instant invention provides plasma membrane vesicles, methods of making the same, and method of using the plasma membrane vesicles.	06-16-2011
20110245104	Method for screening the sensitizing properties of chemical compounds - A method is provided for screening the sensitizing properties of chemical compounds. The method is based on keratinocytes or cells that share important hallmarks of these cells, but other components e.g. proteins could also be used. This method is of importance for several conditions, including but not limited to allergic contact dermatitis (ACD), drug hypersensitivity reactions (DHRs) and autoimmune diseases.	10-06-2011

Brigitte Bayler, Scharndorf AT

Patent application number	Description	Published
20120190438	Gaming Machine and Method Having Bonus Feature Highlighting - A gaming machine and method for displaying and highlighting a scatter symbol among a matrix of symbols. The display includes a first layer for displaying a background and a second layer overlying the first layer. In one embodiment the layers are virtual layers, in another embodiment the layers are discrete physical layers. The second layer displays the matrix of symbols including any scatter symbol included in the matrix of symbols. The second layer enables a gaming machine player to simultaneously view the background, or at least portions of the background. According to one aspect of the invention, the second layer is at least partially transmissive to permit simultaneous viewing of the background and the matrix of symbols. The background is changeable to highlight at least one of the symbols of the matrix of symbols. Preferably, the background highlights the scatter symbol by adding depth, color, light and imagery, such as a still, changing, or moving image.	07-26-2012

Brigitte Benage, Wolcott, CT US

Patent application number	Description	Published
20100093897	COMPOSITION AND METHOD FOR INHIBITING POLYMERIZATION AND POLYMER GROWTH - A method for inhibiting the premature polymerization and the polymer growth of ethylenically unsaturated monomers is disclosed wherein the method comprises adding to said monomers an effective amount of at least one hydrogen donor or electron acceptor. In a preferred embodiment, the hydrogen donor or electron acceptor is used in combination with a stable nitroxyl free radical.	04-15-2010
20100127218	AROMATIC SULFONIC ACIDS, AMINES AND NITROPHENOLS IN COMBINATION WITH NITROXYL RADICAL-CONTAINING COMPOUNDS OR C-NITROSOANILINES AS POLYMERIZATION INHIBITORS - Disclosed herein is a method for inhibiting and retarding the premature polymerization and the polymer growth of vinyl aromatic monomers wherein the method comprises adding to said monomers an effective amount of an inhibitor and retarder blend comprising:	05-27-2010

Brigitte Bourla, Antibes FR

Patent application number	Description	Published
20120310680	METHOD AND SYSTEM FOR OPTIMIZING REVENUE MANAGEMENT IN A TRAVEL ENVIRONMENT - A method of allocating capacity in a vehicle, such as an airplane, which vehicle has a scheduled departure time and a predetermined starting and finishing location and where the capacity includes an inventory of passenger spaces which can be sold to a user is disclosed. The method includes determining at a predetermined time before the scheduled departure time, the number of currently available passenger spaces. The method further includes determining if any of the available passenger spaces can be made available for alternative uses. The method further includes receiving a request for available capacity in the vehicle from a third party to carry a load of cargo having a measure. The method further includes converting the available passenger spaces into an equivalent load having said measure based on a predetermined conversion factor. The method further includes allocating the equivalent load a required capacity. The method further includes updating the number of available passenger spaces now available in the inventory on the basis of the equivalent load and the conversion factor.	12-06-2012

Brigitte Bressac De Paillerets, Sceaux FR

Patent application number	Description	Published
20120252904	MITF AS A MARKER FOR PREDISPOSITION TO CANCER - The present invention relates to a mutant of MITF which is useful as a marker for predisposition to the development of cancer and to uses thereof in diagnosis and preventive treatments, sumoylation being reduced or absent in this mutant.	10-04-2012

Brigitte Caussat, Ramonville Saint Agne FR

Patent application number	Description	Published
20080268143	Device For Providing Vapors Of A Solid Precursor To A Processing Device - The present invention relates to a device for providing vapors of at least one solid precursor intended to supply a physico-chemical processing device, comprising an enclosure capable of containing particles of the solid precursor and comprising an inlet and an outlet, the outlet being intended to be connected to the physico-chemical processing device; and means for circulating a gas between the inlet and the outlet to put the particles of the solid precursor in the form of a fluidized bed, and to convey to the outlet vapors of the solid precursor.	10-30-2008
20120149551	TWO-LAYER CATALYST, PROCESS FOR PREPARING SAME AND USE FOR THE MANUFACTURE OF NANOTUBES - A catalyst material for preparing nanotubes, especially carbon nanotubes, said material being in the form of solid particles, said particles including a porous substrate supporting two superposed catalytic layers, a first layer, directly positioned on the substrate, including at least one transition metal from column VIB of the Periodic Table, preferably molybdenum, and a second catalytic layer, positioned on the first layer, comprising iron. Also, a process for preparing same and to a process for the synthesis of nanotubes using this catalyst material.	06-14-2012

Brigitte Chaumeton, Orsay FR

Patent application number	Description	Published
20120145580	BAG FOR STORING A THERAPEUTIC SOLUTION - The invention relates to a bag (	06-14-2012

Brigitte Chudzik-Raeth, Langenfeld DE

Patent application number	Description	Published
20110056887	REMOVAL OF OXO ANIONS FROM WATER - The present invention relates to a process for removing oxo anions from water and aqueous solutions having a high proportion of silicate by means of a filter arrangement comprising at least one anion exchanger and at least one oxo anion-specific adsorber, and to a filter arrangement to be used for this purpose.	03-10-2011

Brigitte Courtaux, Rueil Malmaison FR

Patent application number	Description	Published
20090327707	Process for creating and managing at least one cryptographic key, and system for its implementation - A process for creating and managing pairs of asymmetrical cryptographic keys and/or certificates associated with the pairs of keys, each pair of keys and associated certificates being intended for an object managed by a computer system. The process includes creating an individual request for creating and/or certifying at least one pair of keys for an object of the system that lacks a pair of keys or a certificate for its pair of keys.	12-31-2009

Brigitte Desloges, Reymure De Vif FR

Patent application number	Description	Published
20110179861	CAPACITIVE HUMIDITY DETECTOR WITH NANOPOROUS HYDROPHILIC DIELECTRIC - A humidity sensor of capacitive type, a device for detecting or measuring humidity including the sensor, and a method to fabricate the sensor. The humidity sensor includes at least one nanoporous dielectric material positioned between at least one first electrode of a capacitor and at least one second electrode of the capacitor.	07-28-2011

Brigitte Duquesroix, Cagnes Sur Mer FR

Patent application number	Description	Published
20100240745	METHOD OF TREATMENT OF INFLAMMATION IN HYPERTENSIVE PATIENTS - The present invention relates to the use of 4-(nitrooxy)-butyl-(S)-2-(6-methoxy-2-naphthyl)-propanoate (naproxcinod) for the treatment of pain and/or inflammation in patients with hypertension treated with renin-angiotensin system blocking agents.	09-23-2010

Brigitte Dyrbusch, Berlin DE

Patent application number	Description	Published
20100119713	PROCESS FOR APPLYING A METAL COATING TO A NON-CONDUCTIVE SUBSTRATE - Described is a new process for applying a metal coating to a non-conductive substrate comprising the steps of (a) contacting the substrate with an activator comprising a noble metal/group IVA metal sol to obtain a treated substrate, (b) contacting said treated substrate with a composition comprising a solution of: (i) a Cu(II), Ag, Au or Ni soluble metal salt or mixtures thereof, (ii) 0.05 to 5 mol/l of a group IA metal hydroxide and (iii) a complexing agent for an ion of the metal of said metal salt, wherein an iminosuccinic acid or a derivative thereof is used as said complexing agent.	05-13-2010

Brigitte Evrand, Verlaine BE

Patent application number	Description	Published
20100261672	PHARMACEUTICAL COMPOSITIONS OF PYRIMIDINE-2,4,6-TRIONES - A trioxopyrimidine-cyclodextrin complex formed of a trioxopyrimidine derivative or a salt thereof and a water-soluble cyclodextrin derivative has improved solubility.	10-14-2010

Brigitte Finkiewicz, Rosharon, TX US

Patent application number	Description	Published
20110146976	DOWNHOLE MULTI-PARALLEL HYDROCYCLONE SEPARATOR - A hydrocyclone separator assembly includes a longitudinal housing configured for disposal in a wellbore, wherein the longitudinal housing comprises a discharge head disposed at one end of the longitudinal housing, wherein the discharge head includes at least one overflow port and at least one underflow port; a plurality of hydrocyclones disposed arranged in a same orientation in the longitudinal housing, wherein the plurality of hydrocyclone each comprise an overflow exit and an underflow exit, wherein at least two of the overflow exits of the plurality of hydrocyclones are connected to a common tubing that is connected to the at least one overflow port on the discharge head, wherein at least two of the underflow exits of the plurality of hydrocyclones are connected to separate tubings that are connected to the at least one underflow port on the discharge head.	06-23-2011

Brigitte Franc Nee Maleville, Paris FR

Patent application number	Description	Published
20100131286	METHODS FOR THE PROGNOSIS OR FOR THE DIAGNOSIS OF A THYROID DISEASE - The present invention relates to methods for predicting or diagnosing a thyroid disease in an individual.	05-27-2010

Brigitte Glaetsch, Heilbronn DE

Patent application number	Description	Published
20100297322	Flavour Enhancer - A flavor enhances for savory food products. A sodium-free and glutamate-free flavor enhance comprising a) an amino acid selected from arginine and/or lysine b) adipic acid C) 50-80% (wt) Kcl d) Optionally an ammonium salt.	11-25-2010

Brigitte Grinschgl, Rodgau DE

Patent application number	Description	Published
20090266273	PULVERULENT COMPOSITION COMPRISING A HYDRAULIC BINDER AND A PYROGENIC METAL OXIDE - Pulverulent composition comprising at least one hydraulic binder having a d	10-29-2009

Brigitte Grouix, Quebec CA

Patent application number	Description	Published
20120088784	Substituted Aromatic Compounds and Pharmaceutical Uses thereof - The present invention relates to substituted aromatic compounds of Formula I and their pharmaceutical uses. Particular aspects of the invention relate to the use of those compounds in the prevention and/or treatment of various diseases and conditions in subjects, including the prevention or treatment of (i) blood disorders, (ii) renal disorders, a nephropathies, or renal disorder complications; (iii) inflammatory-related diseases; and/or (iv) oxidative stress related disorders.	04-12-2012
20120095102	Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof - The present invention relates to salts of 3-pentylphenylacetic acid and their pharmaceutical uses. Particular aspects of the invention relate to the use of those salts in the prevention and/or treatment of various diseases and conditions in subjects, including the prevention and treatment of (i) blood disorders, (ii) renal disorders and renal disorder complications; (iii) inflammatory-related diseases; and/or (iv) oxidative stress related disorders.	04-19-2012

Brigitte Grouix, Montreal CA

Patent application number	Description	Published
20090068169	2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use - The present invention describes new compounds which are useful for binding to the tail or Fc portion of immunoglobulins and so have utility in those applications which require the non-covalent binding interaction of a molecule with the Fc portion of immunoglobulins. Such applications include the detection and purification of immunoglobulins as well as the treatment of certain autoimmune diseases.	03-12-2009
20100129350	Triazine Derivatives, Compositions Containing Such Derivatives, and Methods of Treatment of Cancer and Autoimmune Diseases Using Such Derivatives - We describe compounds of the following general formula (I): wherein X is fluorine or chlorine; Y is oxygen, sulfur, or an amino group; R is an amino, hydroxyl, sulfonamide, or carboxamide group or an N-monomethyl or N-dimethyl analog thereof; m is an integer from 2 to 6, and n is an integer from 0 to 2. The compounds may be used for treating certain cancers and autoimmune diseases.	05-27-2010
20130217645	Compounds and Compositions for the Treatment of Cancer - New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I, Formula I.1, Formula I.2, Formula IA, Formula IB, Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine, doxorubicin, daunorubicin, cyclophosphamide, busulfex, busulfan, vinblastine, vincristine, bleomycin, etoposide, topotecan, irinotecan, taxotere, taxol, 5-fluorouracil, methotrexate, gemcitabine, cisplatin, carboplatin and chlorambucil.	08-22-2013

Brigitte Heckl-Oestreicher, Heidelberg DE

Patent application number	Description	Published
20100249055	CLOFARABINE PHOSPHOLIPID DERIVATIVES - The subject of the present invention are specific phospholipidesters of clofarabine and the use of such lipidesters in the treatment of tumors.	09-30-2010

Brigitte Hennebois, Ginasservis FR

Patent application number	Description	Published
20130100825	METHOD FOR MANAGING COMMUNICATION BETWEEN AN ELECTRONIC DEVICE, FOR EXAMPLE A CONTACTLESS CHIP CARD, AND A COMMUNICATION APPARATUS, FOR EXAMPLE A READER, AND CORRESPONDING ELECTRONIC DEVICE - The device is equipped with several protocol decoding means (DCDi) corresponding respectively to various communication protocols so as to be capable of dialoguing with the said communication apparatus during transactions selectively according to one of these communication protocols; the method comprises an automatic protocol detection comprising a) an activation (	04-25-2013

Brigitte Jamart-Gregoire, Nicolas FR

Patent application number	Description	Published
20120097884	USE OF AEROGELS FOR PREPARING A MATERIAL FOR THERMAL INSULATION - Material for thermal insulation including an aerogel obtained by drying an organogel prepared from the pseudopeptides of formula (I).	04-26-2012

Brigitte Kerfelec, Marseille FR

Patent application number	Description	Published
20140037631	ANTIGEN BINDING FORMATS FOR USE IN THERAPEUTIC TREATMENTS OR DIAGNOSTIC ASSAYS - The present invention relates to antigen binding formats for use in therapeutic treatments or diagnostic assays. The present invention relates to an antigen-binding format consisting of: a first fusion protein wherein the CH1 constant domain of an antibody is fused i) by its N-terminal end to the C-terminal end of a variable domain of an antibody and ii) by its C-terminal end to the N-terminal end of a variable domain of an antibody and, a second fusion protein wherein the CL constant domain of an antibody is fused by its N-terminal end to the C-terminal end of a variable domain of an antibody.	02-06-2014

Brigitte Lange, Berlin DE

Patent application number	Description	Published
20140066666	Method For Producing 1,2-Pentanediol - A process for the preparation of 1,2-pentanediol by reaction of a starting material comprising one or both compounds from the group consisting of furfuryl alcohol and furfural with hydrogen in the presence of a first heterogeneous catalyst is described.	03-06-2014

Brigitte Larroche, Paris FR

Patent application number	Description	Published
20100218460	PROCESS AND INSTALLATION FOR THE CONTINUOUS VACUUM PREPACKING OF FOOD PRODUCTS - Process for the continuous vacuum prepacking of food products that can be pasteurized and/or sterilized in a container closed by a cover that has no hooking element and is equipped with an elastic seal maintained by a forced vacuum, and the cover is opened by a vacuum-breaking system. During the placing under vacuum, the cover is kept apart from the previously filled container, superheated vapor is injected at a temperature, a flow rate and/or a time that allow the sterilization of the cover and the head space of the container by expelling air and incondensable products, in particular oxygen; the container is then pressed against the cover or vice versa, and a jet of cold water is sent onto the cover, which causes rapid cooling of the cover, the immediate condensation of the vapor phase in the head space of the container that allows the placing under deep vacuum.	09-02-2010

Brigitte Lesaffre, Saint-Denis FR

Patent application number	Description	Published
20090131320	PEPTIDES MODULATING THE ACTIVITY OF THE ENGRAILED TRANSCRIPTION FACTOR - The invention relates to peptides which can become fixed to the engrailed transcription factor and which can modulate the activity thereof.	05-21-2009

Brigitte Madly, Montpellier Cedex 5 FR

Patent application number	Description	Published
20130101600	CXCL5 AS A MARKER OF HORMONE ESCAPE IN PROSTATE CANCER - The invention relates to the use of CXCL5 as a marker for assessing hormone escape in prostate cancer cells. The invention further provides diagnostic methods and kits for assessing hormone escape in prostate cancer cells, and CXCL5 antagonists for use in the treatment or prevention of prostate cancer and/or hormone escape in prostate cancer.	04-25-2013

Brigitte Malette, Montreal CA

Patent application number	Description	Published
20120208869	Endometriosis-Related Markers and Uses Thereof - The present invention relates to markers of endometriosis which are differentially expressed in the endometrial cells of females with endometriosis compared to endometriosis-free females. The invention also relates to methods for determining likelihood of endometriosis in female subjects, to methods for grading endometriosis in females suffering from endometriosis and to methods for treating this disease. The invention is also concerned with polynucleotides, probes, primers and kits useful for reducing into practice the above-mentioned methods which are more rapid, non invasive, much less complicated and much less costly than laparoscopy.	08-16-2012

Brigitte Martin, Saint-Egreve FR

Patent application number	Description	Published
20100059477	Formation of Deep Hollow Areas and use Thereof in the Production of an Optical Recording Medium - At least one hollow zone is formed in a stack of at least one upper layer and one lower layer. The upper layer is patterned to form at least a first hollow region passing through said upper layer. The first hollow region is extended by a second hollow region formed in the lower layer by etching through an etching mask formed on the patterned upper layer. The etching mask is formed by a resin layer, positively photosensitive to an optic radiation of a predetermined wavelength, exposed to the said optic radiation through the stack and developed. The lower and upper layers of the stack are respectively transparent and opaque to said predetermined wavelength so that the patterned upper layer acts as exposure mask for the resin layer.	03-11-2010

Brigitte Mouanda, Arnoult-En-Yvelines FR

Patent application number	Description	Published
20120196035	METHOD FOR MODIFYING THE SURFACE ENERGY OF A SOLID - A method for modifying the surface energy of at least one surface of a solid is provided. The method may comprise a step consisting of grafting, on the surface, a polymeric organic film consisting of graft polymers, each polymer having a first unit bound directly to the surface derived from a cleavable aryl salt and at least one other unit of the polymer chain derived from a component selected from the group consisting of a cleavable fluorinated aryl salt, a fluorinated (meth)acrylate and a vinyl-terminated siloxane. In addition, a kit for implementation of the method is provided.	08-02-2012

Brigitte Mouanda, Saint Arnoult En Yvelines FR

Patent application number	Description	Published
20100279900	SOLID SUPPORT COMPRISING A FUNCTIONALIZED ELECTRICITY CONDUCTOR OR SEMICONDUCTOR SURFACE, METHOD FOR PREPARING SAME AND USES THEREOF - The present invention provides a method for encapsulating biocompatible polymers. The method comprises using a solid support comprising at least one electrically conducting and/or semiconducting region containing a reducible oxide on its surface, wherein at least one zone of this surface is functionalized with an electrografted organic film obtained from electroactive organic precursors each comprising at least one functional group of interest, and wherein the number of functional groups of interest accessible for the formation of a covalent, ionic or hydrogen bond with a complementary group within said film represents at least 90% of the total number of functional organic groups of interest, and wherein the density of the accessible functional groups of interest is between 10	11-04-2010

Brigitte Mouanda, Saint Arnault En Yvelines FR

Patent application number	Description	Published
20100270166	Method of Forming an organic Film Using a Gel, Said Gel and Use Thereof - The invention relates to a process for forming a polymeric organic film on an electrically conductive or semiconductive surface by application of an electric potential between a gel, in contact with said surface, and said surface, the gel comprising (i) a protic solvent, (ii) compounds having colloidal properties, (iii) an adhesion primer, optionally (iv) a monomer and the potential applied being at least equal to the reduction potential of the adhesion primer. The invention also relates to said gel, to its use and to a kit for forming an organic film.	10-28-2010

Brigitte Nink-Grebe, Giessen DE

Patent application number	Description	Published
20140057234	DEVICE FOR TRAINING THE APPLICATION OF COMPRESSION MATERIAL - The invention relates to the training and monitoring of a correct application of compression material. A training extremity (	02-27-2014

Brigitte Onteniente, Creteil FR

Patent application number	Description	Published
20090118180	USE OF FUSION PROTEINS FOR THE PREVENTION OR THE TREATMENT OF PATHOLOGIES RESULTING FROM ISCHEMIA - The present invention relates to the use of a fusion protein including a peptide sequence having membrane transducing properties, and a peptide sequence having cell survival properties, or a nucleic acid coding for the fusion protein, for the manufacture of a medicament intended for the prevention or the treatment of pathologies resulting from ischemia.	05-07-2009

Brigitte Papahadjopoulos-Sternberg, San Francisco, CA US

Patent application number	Description	Published
20120237562	ANTIBIOTIC DRUG DELIVERY AND POTENTIATION - Disclosed are compositions-of-matter comprising polymer-mediated cochleates, which are formed from a calcium-free mixture of a wide variety of phospholipids that are atypical for forming cochleates. Further disclosed are compositions-of-matter comprising these cochleates which co-encapsulate another bioactive agent. The polymer mediating the formation of these cochleates exhibits a plurality of positively charged amino acid residues and omega-amino-fatty acid moieties, and may further exhibit antimicrobial, anticancerous and drug-potentiating activity. Further disclosed are pharmaceutical compositions and methods using the compositions-of-matter disclosed herein, and processes of preparing same.	09-20-2012

Brigitte Pecquenard, Talence FR

Patent application number	Description	Published
20100136436	LITHIUM ION CONDUCTING LITHIUM SULPHUR OXYNITRIDE THIN FILM, AND A PROCESS FOR THE PREPARATION THEREOF - The disclosure herein relates to a lithium ion conducting electrolyte. This electrolytic material has improved ionic conductivity. The material disclosed herein is an amorphous compound of the formula Li	06-03-2010
20110020702	IRON-DOPED VANADIUM(V) OXIDES - The present invention relates to iron-doped vanadium(V) oxides of formula Fe	01-27-2011
20110147207	Method for Manufacturing of Sputtering Targets Using an Inorganic Polymer - The invention relates to a cathodic sputtering target composition comprising at least a solid lithium-based electrolyte and an inorganic carbon free polymer, and to a method for the manufacturing of cathodic solid sputtering targets using such a composition. The invention also relates to solid sputtering targets obtained by such a method and to their use for the preparation of solid thin films by a sputtering physical vapour deposition process, in particular for the preparation of solid electrolyte thin films inside thin film batteries.	06-23-2011

Brigitte Pigeat, Lyon FR

Patent application number	Description	Published
20090088595	Process for producing propylene in the presence of a macroporous catalyst in the form of spherical beads - A process for once-through conversion of a hydrocarbon feed comprising at least olefins containing 4 carbon atoms and at least olefins containing 5 carbon atoms is described for the production of propylene, said process comprising passing said feed into at least one reaction unit provided with at least one catalyst in the form of spherical beads with a diameter in the range 1 to 3 mm, each of said spherical beads comprising at least one zeolite and at least one alumina-based support and having a pore distribution such that the macroporous volume, measured by mercury porosimetry, is in the range 0.10 to 0.20 ml/g and the mesoporous volume, measured by mercury porosimetry, is in the range 0.25 to 0.35 ml/g.	04-02-2009

Brigitte Pohn, Graz AT

Patent application number	Description	Published
20110137002	METHOD FOR THE ENZYME-CATALYSED HYDROLYSIS OF POLYACRYLIC ACID ESTERS, AND ESTERASES USED THEREFOR - The invention relates to a method for the enzyme-catalysed hydrolysis of polyacrylic acid esters. According to said method, at least one polyacrylic acid ester is provided and incubated with at least one enzyme selected from enzymes (EC 3.1) acting on ester bindings, until the ester groups contained in the polyacrylic acid ester are partially or fully hydrolytically split, and optionally the modified polymer obtained thereby is isolated. The invention also relates to the enzymes used and mutants thereof, nucleic acids coding for the enzymes, vectors comprising the nucleic acids, micro-organisms comprising the vectors, and the use of the enzymes, the vectors or the micro-organisms for carrying out a method for the enzyme-catalysed hydrolysis of polyacrylic acid esters. The present application also relates to polymer reaction products that can be obtained by the method, and methods for producing esterases.	06-09-2011
20140100338	Method for the Enzyme-Catalysed Hydrolysis of Polyacrylic Acid Esters, and Esterases Used Therefor - The invention relates to a method for the enzyme-catalysed hydrolysis of polyacrylic acid esters. According to said method, at least one polyacrylic acid ester is provided and incubated with at least one enzyme selected from enzymes (EC 3.1) acting on ester bindings, until the ester groups contained in the polyacrylic acid ester are partially or fully hydrolytically split, and optionally the modified polymer obtained thereby is isolated. The invention also relates to the enzymes used and mutants thereof, nucleic acids coding for the enzymes, vectors comprising the nucleic acids, micro-organisms comprising the vectors, and the use of the enzymes, the vectors or the micro-organisms for carrying out a method for the enzyme-catalysed hydrolysis of polyacrylic acid esters. The present application also relates to polymer reaction products that can be obtained by the method, and methods for producing esterases.	04-10-2014

Brigitte Purmann, Muhlheim DE

Patent application number	Description	Published
20110092600	PHARMACEUTICAL COMPOSITIONS COMPRISING AMINOCYCLOHEXANE DERIVATIVES - The present invention relates to pharmaceutical compositions comprising 1-aminocyclohexane derivatives and a cyclodextrin, which compositions exhibit advantageous safety, convenience, and dosing characteristics. The compositions of the instant invention find particular application in the treatment of various diseases and conditions of the CNS, including those involving the impairment of cognitive function or dementia, such as Alzheimer's disease.	04-21-2011
20130142870	NERAMEXANE MULTIPLE UNIT DOSAGE FORM - Unit comprising neramexane, a pharmaceutically acceptable salt, solvate, conjugate, prodrug, polymorphic form, isomer, or derivative thereof; and a release-controlling excipient; wherein said unit has a diameter of from 0.1 to less than 6 mm.	06-06-2013

Brigitte Quatannens, Mandelieu-Ia-Napoule FR

Patent application number	Description	Published
20130224784	METHOD FOR ASSESSING THE EFFICACY OF A TR1 CELL THERAPY IN A SUBJECT - A method for assessing whether a patient subjected to an antigen-specific Tr1 cell therapy is responding to the treatment, includes: determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from the patient; and comparing the antigen-specific proliferation to a standard reference, thereby determining whether the patient is responding or not to the treatment.	08-29-2013

Brigitte Quatannens, Mandelieu-La-Napoule FR

Patent application number	Description	Published
20130101568	IL-13 PRODUCING TR1-LIKE CELLS AND USE THEREOF - The present invention relates to an isolated Tr1-like cell population capable of producing IL-13, the population having immunosuppressive activities; methods for identifying/isolating/enriching the population and its uses thereof.	04-25-2013

Brigitte Quattannens, Mandelieu-La Napoule FR

Patent application number	Description	Published
20130034528	NEW METHODS FOR ISOLATING TR1 CELLS - The present invention relates to methods for isolating Tr1 cells, resting Tr1 cells and/or activated Tr1 cells, to methods for enriching or depleting a cell population in Tr1 cells, resting Tr1 cells and/or activated Tr1 cells and to methods and kits for treating chronic inflammatory diseases, autoimmune diseases, allergic diseases, cancer and organ transplantation conditions.	02-07-2013

Brigitte Rennert, Neuss DE

Patent application number	Description	Published
20100323163	SEED CRYSTAL COATING FOR GYPSUM WALLBOARD FACING - Facing material useful in the manufacture of gypsum wallboard is surfaced treated in order to adhere an amount of seed crystals to improve the adhering affinity of the facing material for wet plaster thereby permitting the manufacture of gypsum wallboard with little or no added starch and reduced amounts of water. Various means for adhering the seed crystals to the facing material are described as well as, a method of converting the facing material and wallboards containing the facing material are also described.	12-23-2010
20120315489	CELLULOSE ETHER COMPOUNDS FOR IMPROVED HOT TEMPERATURE PERFORMANCE IN EXTERNAL INSULATION FINISHING SYSTEMS (EIFS) MORTARS - The present invention relates to mortars which include a blend of cellulose ether compounds and exhibit improved pot life, water retention capability, and open time, as well as high tensile strength values. These mortars can be used in the fabrication of external insulation finishing systems (EIFS), particularly in hot environments. The cellulose ether blend includes hydroxyethylcellulose ether and methylhydroxyethylcellulose ether. Water soluble anionic polyacrylamide and hydroxypropyl starch can also be added to the mortar.	12-13-2012

Brigitte Reveil, Reims FR

Patent application number	Description	Published
20090305311	C4D/C4B STANDARD FOR QUANTITATIVE FLOW CYTOMETRY OF HUMORAL TRANSPLANT REJECTION - The invention concerns an internal standard used to quantitative analysis of the risk of humoral (i.e. vascular) transplant rejection. The internal standard consists of a stable composition of the C4d complement bound to a carrier consisting of erythrocytes or microparticles. The invention also concerns a method for analyzing in vitro the risk of humoral organ transplant rejection, which consists in determining the amount of component of C4d component fixed on the erythrocytes contained in a blood sample from a patient.	12-10-2009

Brigitte Rosemeier, Vlotho DE

Patent application number	Description	Published
20090301043	FILTER BAG - A filter bag includes a first filter material layer including an inflow opening, a second filter material layer having edges along which the second filter layer is joined to the first filter material layer to form an inside space; and a flat, multi-layer filter insert arranged in the inside space and having sections connected, respectively, to the first and second material layers. The filter insert has at least two outer layers defining an intermediate area there between. The intermediate area includes a center layer or an intermediate space for dust collection.	12-10-2009

Brigitte Roth, Waiblingen DE

Patent application number	Description	Published
20100269792	PRESSURE REGULATING VALVE FOR REGULATING THE PRESSURE IN A HIGH-PRESSURE RESERVOIR - The invention relates to a machine tool having working field illumination disposed in a housing, having an illumination mechanism and a transparent element which allows the light from the illumination mechanism to be led out toward the working field. A light beam can be deflected between the illumination mechanism and the transparent element. According to the invention, the transparent element forms a region of the housing.	10-28-2010
20110140016	PRESSURE-REGULATING VALVE FOR REGULATING THE PRESSURE IN A HIGH-PRESSURE FUEL ACCUMULATOR OF AN INTERNAL COMBUSTION ENGINE - A pressure-regulating valve for regulating the pressure in a high-pressure fuel accumulator of an internal combustion engine, in particular in common-rail injection systems, with a valve piston (	06-16-2011

Brigitte Rubo, Linden DE

Patent application number	Description	Published
20110147401	Flexible Container And Reusable Closure Element - An assembly offering to consumers a choice between two types of closure systems for a wipes flexible container is provided. The assembly comprises at least one flexible container and a reusable closure element.	06-23-2011

Brigitte Ruscica, Grasse FR

Patent application number	Description	Published
20090083056	Method and apparatus for version management of a data entity - A system for identifying a parameter in a version of a data entity created at a specific time, wherein at a first time the version is an active version and at a second time the version is a previous version, the system comprising: a database for storing the plurality of versions of the data entity as they are created; a cache for storing the first active version of the data entity; wherein when a new version of the data entity is created by updating at least one parameter of the data entity, a new active version replaces the first active version stored in a cache and the first active version becomes a previous version stored in the cache; and wherein the new active version includes a list of the or each previous version of the data entity with an associated time at which the version was an active version, such that by identifying the version of the data entity which was active at the specific time the parameter is determined.	03-26-2009
20100114830	METHOD OF INTEGRATING IN REAL TIME LARGE VOLUMES OF UPDATES IN A DATABASE - A method of integrating large volumes of updates in a database system is described. Each individual update is comprised of a coherent set of data records supplied by a data provider. The database system includes a master file repository and an active image repository. The method comprises the steps of first obtaining for each individual update a unique modification identifier from a logistic table of the database system. The master file repository is then updated with the coherent set of data records of each uniquely identified individual update. A unique commit identifier is further obtained from the logistic table for each individual update that has been committed by the master file. The active image repository is synchronized by successively loading into the active image, in the order specified by the commit identifier, each individual update. Synchronization includes retrieving from the master file repository the coherent set of data records of each uniquely identified individual update. Finally, completion of the propagation of each individual update into the active image repository is achieved when the loading of each corresponding set of data records is committed by the active image.	05-06-2010
20100211550	METHOD ALLOWING VALIDATION IN A PRODUCTION DATABASE OF NEW ENTERED DATA PRIOR TO THEIR RELEASE - A method of insuring the integrity of a plurality of updates brought in real-time to a production database concurrently used by one or more software applications is described. The production database includes a plurality of products participating to the definition of objects. The method first includes requesting the issuance of a unique filing number associated to a draft state version of the plurality of updates while keeping them invisible to the end-users of the production database. Then, a set of product items identified as a whole by the unique filing number are created or copied from the production database and gathered under the form of a meta-product on which the plurality of updates is applied. After updating, the meta-product is successively set into a customizable flow of one or more validation states in order to perform a cross-validation of the plurality of updates. After validation, the meta-product is set into a production state where the uniquely identified meta-product becomes immediately visible and useable by the end-users.	08-19-2010
20120059802	METHOD ALLOWING VALIDATION OF LARGE VOLUME OF UPDATES IN A LARGE PRODUCTION DATABASE OF NEW ENTERED DATA PRIOR TO THEIR RELEASE - A method of insuring the integrity of a plurality of updates brought in real-time to a large production database concurrently used by one or more software applications is described. The large production database includes a plurality of products participating to the definition of objects. The method first comprises the step of requesting the issuance of a unique filing number associated to a draft state version of the plurality of updates while keeping them invisible to the end-users of the large production database. Then, a set of product items identified as a whole by the unique filing number and on which the updates applies is created or copied in the large production database and gathered under the form of a meta-product on which the plurality of updates is applied. When updating is complete, the meta-product is successively set into a customizable flow of one or more validation states in order to perform a cross-validation of the plurality of updates. Finally, when validation is complete, the meta-product is set into a production state where the uniquely identified meta-product becomes immediately visible and useable by the end-users of the one or more software applications.	03-08-2012

Brigitte Schimrosczyk, Stapelburg DE

Patent application number	Description	Published
20110088513	METHOD FOR SOLUBILIZING MOLYBDENUM OXIDE CONCENTRATES - A process for digesting molybdenum oxide concentrates includes suspending a molybdenum-containing starting material in an aqueous solution so as to obtain a suspension. While stirring, an oxidizing agent and an alkali solution of at least one alkali metal are metered to the suspension so as to set a pH and produce a product having a molybdenum content of at least 98% of the molybdenum-containing starting material. The alkali metal is selected from the group consisting of Na, K and Li.	04-21-2011

Brigitte Schmidt, Lorrach DE

Patent application number	Description	Published
20080262225	Use of metal complex compounds as oxidation catalysts - Use of metal complex compounds of formula	10-23-2008
20090068282	Use of metal complex compounds as oxidation catalysts - Use of metal complex compounds of formula	03-12-2009

Brigitte Sehrbrock, Julich DE

Patent application number	Description	Published
20080296262	Process and Device for Cleaning and Etching a Substrate Wi - A simple process is disclosed for treating substrates having pre-structured zinc oxide layers on rigid or flexible supports. The ZnO is treated with an etching medium then with a cleaning liquid. The treatment with the etching and cleaning liquids is carried out while the substrate is conveyed through a device. The process is technically simple to implement and makes it possible to regularly and homogeneously roughen and texturise ZnO layers of up to 1 m	12-04-2008

Brigitte Serreault, Sceaux FR

Patent application number	Description	Published
20130121364	LASER CAVITY WITH CENTRAL EXTRACTION BY POLARISATION FOR COHERENT COUPLING OF INTENSE INTRA-CAVITY BEAMS - The invention relates to a laser cavity with central extraction by polarisation for coherent coupling of intense intra-cavity beams. The laser cavity (	05-16-2013
20130342896	METHOD AND LASER OSCILLATOR FOR THE GENERATION OF A LASER BEAM - Method and laser oscillator for the generation of a laser beam—According to the invention with a view to adjusting, inside said laser oscillator (	12-26-2013

Brigitte Shaughness, Grand Cayman KY

Patent application number	Description	Published
20110108444	Brush Cover - A protective brush cover is described for use with a makeup brush. In some versions, the protective brush cover comprises a body and a closing feature. In some versions the protective brush cover comprises a body, a lid, and a securing feature. In some versions, the body is operable to hold the head of a makeup brush, and the body may further have an opening such that the handle of the makeup brush may extend through the opening.	05-12-2011
20120024734	BRUSH COVER - A protective brush cover is described for use with a makeup brush. In some versions, the protective brush cover comprises a body and a closing feature. In some versions the protective brush cover comprises a body, a lid, and a securing feature. In some versions, the body is operable to hold the head of a makeup brush, and the body may further have an opening such that the handle of the makeup brush may extend through the opening.	02-02-2012

Brigitte Skalsky, Gross-Gerau DE

Patent application number	Description	Published
20110033530	COATING COMPOSITION FOR THE DIP COATING OF CAPSULE HALVES - A coating composition for the enteric coating of capsule halves made of water-soluble or water-swellable polymer material in a dipping process is provided. The composition is an aqueous dispersion or solution, containing a polymer mixture of at least one first (meth)acrylate copolymer, which is enteric, and at least one further (meth)acrylate copolymer, which is enteric or water-insoluble, and also auxiliaries which influence the viscosity of the dispersion and the elasticity of the dried polymer film. The solids content of the dispersion or solution is more than 25% by weight and the viscosity is 150 to 1500 mPa·s and a dried film produced from the dispersion or solution has an elongation at break of at least 200%. Also provided is a capsule composed of two capsule halves coated with the dispersion or solution in a dipping process does. The enteric capsule does not dissolve in 0.1 N HCl at pH 1.2 after two hours, but completely dissolves in buffer at pH 6.8 in less than 30 minutes. A method to prepare enteric coated capsule halves is also provided.	02-10-2011

Brigitte Spinnewyn, Bures Sur Yvette FR

Patent application number	Description	Published
20080207709	Thiazole Derivatives for Treating Dyskinesias Caused by a Chemical Treatment - The invention relates to the use of derivatives of thiazoles having general formula (I) for the preparation of a medicament for the treatment or prevention of dyskinesias caused by a chemical treatment. The invention also relates to a combination of thiazole derivatives having general formula (I) and at least one compound selected from among neuroleptics or products that act on the dopaminergic system for the treatment or prevention of dyskinesias caused by a chemical treatment.	08-28-2008

Brigitte Steder, Karlsruhe DE

Patent application number	Description	Published
20090200263	METHOD FOR METALLIZING INSULATING SUBSTRATES WHEREIN THE ROUGHENING AND ETCHING PROCESSES ARE CONTROLLED BY MEANS OF GLOSS MEASUREMENT - The invention relates to a control of etching processes of insulating substrates by means of gloss measurement. By this method a surface roughness can be achieved which leads to good adhesion of metals layers deposited in subsequent metallization steps. This method is particularly suited for the production of printed circuit boards.	08-13-2009

Brigitte Stroetmann, Aisch DE

Patent application number	Description	Published
20110161098	METHOD AND SYSTEM FOR ACCESSING A PLURALITY OF MEDICAL DATA SOURCES - An embodiment of the invention explains a method and system for accessing medical data. The method involves providing access to medical data from the plurality of medical data sources and then correlating the medical data from the plurality of sources based on predefined rules. Then a medical expert reviews the correlated medical data by medical expert and associate expert information from the medical expert regarding the correlation of the medical data from different sources to the medical data.	06-30-2011

Brigitte Taravella, Paris FR

Patent application number	Description	Published
20100048526	PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL OR TRANSMUCOUS ADMINISTRATION - The present invention relates to a novel pharmaceutical composition for transdermal or transmucous administration of at least one active substance, and comprising especially a fatty acid as a percutaneous absorption promoter, at least one alcoholic vehicle and also a stabilizer capable of stabilizing the fatty acid in the said pharmaceutical composition.	02-25-2010
20120122829	PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL OR TRANSMUCOUS ADMINISTRATION - The present invention relates to a novel pharmaceutical composition for transdermal or transmucous administration of at least one active substance, and comprising especially a fatty acid as a percutaneous absorption promoter, at least one alcoholic vehicle and also a stabilizer capable of stabilizing the fatty acid in the said pharmaceutical composition.	05-17-2012
20120157423	Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - The present invention relates to a pharmaceutical composition in the form of a hydro-alcoholic gel or a solution for transdermal application, comprising:	06-21-2012

Brigitte Tempelmaier, Vienna AT

Patent application number	Description	Published
20130034575	METHOD FOR IDENTIFICATION, ISOLATION AND PRODUCTION OF ANTIGENS TO A SPECIFIC PATHOGEN - Described is a method for identification, isolation and production of hyperimmune serum-reactive antigens from a specific pathogen, a tumor, an allergen or a tissue or host prone to auto-immunity, said antigens being suited for use in a vaccine for a given type of animal or for humans, which is characterized by the following steps: providing an antibody preparation, providing at least one expression library, identifying antigens which bind, screening the identified antigens, identifying the hyperimmune serum-reactive antigen portion of said identified antigens and which hyperimmune serum-reactive antigens bind to a relevant portion of said individual antibody optionally isolating said hyperimmune serum-reactive antigens and producing said hyperimmune serum-reactive antigens by chemical or recombinant methods.	02-07-2013

Brigitte Ternaux, Villepreux FR

Patent application number	Description	Published
20110014159	METHOD FOR OBTAINING CHARACTERIZED MUSCLE-DERIVED CELL POPULATIONS AND USES - A method for obtaining cell populations derived from the muscular tissue and their use for preparing cell therapy products includes culturing cells previously removed by biopsy from skeletal muscular tissues, identifying the different types of cells present at different stages of culture, selecting the culture stage on the basis of the required cell population and collecting the selected culture stage for preparing a cell therapy product. The invention also concerns cell populations derived from muscular tissue obtained by implementing the method whereof the dominant cell type is CD34+, CD15+ or CD56+ or Class 1+HLA, or comprises a doubly negative CD56−/CD15− cell type or may comprise more minority CD10+, Stro-1+ and CD 117+ cell types.	01-20-2011

Brigitte Thoerner, Duesseldorf DE

Patent application number	Description	Published
20120101060	SKIN PROTECTANT, PARTICULARLY AGAINST HYDROPHOBIC (LIPOPHILIC) AND AGAINST HYDROPHILIC (LIPOPHOBIC) HARMFUL SUBSTANCES - The invention relates to a skin protectant, particularly against hydrophobic (lipophilic) and hydrophilic (lipophobic) harmful substances, obtainable by means of an amount of at least one barrier-forming component, particularly against hydrophobic (lipophilic) harmful substances, wherein the nephelometric turbidity unit of the barrier-forming component is determined by means of turbidimetry and at least one barrier-forming component, a 1% solution in water thereof having a nephelometric turbidity unit of greater than 40 (NTU), is used to produce the protectant and a method for producing skin protectants, particularly against hydrophobic (lipophilic) and hydrophilic (lipophobic) harmful substances, where in the barrier-forming component is selected for production of the protectant such that the nephelometric turbidity unit of the barrier-forming component of the skin protectant is determined by means of turbidimetry and at least one barrier-forming component, a 1% solution in water thereof having a nephelometric turbidity unit of greater than 40 (NTU), is used to produce the skin protectant.	04-26-2012
20130237468	SKIN CLEANSING AGENT, PARTICULARLY FOR REMOVING PRINTING INKS AND/OR SOILING CAUSED BY INK - The invention relates to a skin cleansing agent, particularly for the removal of printing colors and/or inks, comprising the components	09-12-2013

Brigitte Thomasset, Compiegne FR

Patent application number	Description	Published
20090271892	LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE GENES AND USES THEREOF - The present invention relates to the identification and characterization of new lysophosphatidic acid acyltransferases (LPAAT) as well as to the use of these enzymes for modifying plants for efficient production of modified lipids.	10-29-2009

Brigitte Vermelle, Lancon De Provence FR

Patent application number	Description	Published
20100235281	Method Guaranteeing Payment for Electronic Commerce in Particularly by Mobile Telephone and a System Implementing It - An electronic payment method for a retailer using an operator network and a financial organization. During a transaction two certificates are produced; one using an operator key and the other using a banking key. The first certificate is sent to the operator and the other certificate is securely placed under the control of the financial organization.	09-16-2010

Brigitte Winther Lund, Bagsvaerd DK

Patent application number	Description	Published
20120088825	COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS - Disclosed herein are compounds of Formula I	04-12-2012

Brigitte Zednik, Au Am Leithagebirge AT

Patent application number	Description	Published
20120321858	MOLDINGS DESIGNED TO PREVENT FALLS - Molding composed of metal-network-reinforced plastic in the form of a domelight, and production process for same.	12-20-2012